Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selectis HealthGBCS -0.07%47 EV-to-FCF is -16.08 as of Jul. 21, 2026. GuruFocus rates GBCS with a GF Score™ of 47/100 and a GF Value™ of $2.14 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Selectis Health ranks worse than 246913.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Selectis Health's Enterprise Value is $32.89 Mil.
Selectis Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.05 Mil. Therefore, Selectis Health's EV-to-FCF for today is -16.08.
The historical rank and industry rank for Selectis Health's EV-to-FCF or its related term are showing as below:
GBCS'
s EV-to-FCF Range Over the Past 10 Years
Min: -999.23 Med: -16.91 Max: 568.61
Current: -16.08
During the past 13 years, the highest EV-to-FCF of Selectis Health was 568.61. The lowest was -999.23. And the median was -16.91.
GBCS's EV-to-FCF is ranked worse than 100% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.06
vs GBCS: -16.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Selectis Health (OTCPK:GBCS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Selectis Health's PE Ratio (TTM) for today is calculated as:
Selectis Health's share price for today is $5.2962.
Selectis Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Selectis Health EV-to-FCF Related Terms
Selectis Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Selectis Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Selectis Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Selectis Health's EV-to-FCF falls into.
Selectis Health's current Enterprise Value is $32.89 Mil.
Selectis Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a EV-to-FCF of -16.08 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #999999 out of 405 companies in the Healthcare Providers & Services industry.
Is Selectis Health's EV-to-FCF too high?
Selectis Health's current EV-to-FCF is -16.08. Based on the distribution chart, Selectis Health ranks #999999 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Selectis Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's EV-to-FCF compare to CCM and BMGL?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #999999 out of 405 companies for EV-to-FCF. This places Selectis Health in the lower half of its industry. The industry median EV-to-FCF is 18.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.06, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Selectis Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selectis Health's current EV-to-FCF is -16.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.14, compared to a current price of $5.30 — trading 147.5% above its estimated fair value. The current EV-to-FCF is -16.08. Selectis Health's overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Selectis Health (GBCS), the current EV-to-FCF is -16.08 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.30 is trading 147.5% above its estimated GF Value™ of $2.14.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
EV-to-FCF: -16.08
GF Value™: $2.14 vs. price of $5.30 (147.5% above fair value)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
47GF Score
Get the complete analysis for GBCS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
